Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,407 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Arsenic Trioxide Enhances the NK Cell Cytotoxicity Against Acute Promyelocytic Leukemia While Simultaneously Inhibiting Its Bio-Genesis.
Alex AA, Ganesan S, Palani HK, Balasundaram N, David S, Lakshmi KM, Kulkarni UP, Nisham PN, Korula A, Devasia AJ, Janet NB, Abraham A, Srivastava A, George B, Padua RA, Chomienne C, Balasubramanian P, Mathews V. Alex AA, et al. Among authors: abraham a. Front Immunol. 2018 Jun 14;9:1357. doi: 10.3389/fimmu.2018.01357. eCollection 2018. Front Immunol. 2018. PMID: 29963052 Free PMC article.
Dendritic cell count in the graft predicts relapse in patients with hematologic malignancies undergoing an HLA-matched related allogeneic peripheral blood stem cell transplant.
Rajasekar R, Lakshmi KM, George B, Viswabandya A, Thirugnanam R, Abraham A, Chandy M, Srivastava A, Mathews V. Rajasekar R, et al. Among authors: abraham a. Biol Blood Marrow Transplant. 2010 Jun;16(6):854-60. doi: 10.1016/j.bbmt.2010.01.013. Epub 2010 Feb 4. Biol Blood Marrow Transplant. 2010. PMID: 20138229 Free article. Clinical Trial.
Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: long-term follow-up data.
Mathews V, George B, Chendamarai E, Lakshmi KM, Desire S, Balasubramanian P, Viswabandya A, Thirugnanam R, Abraham A, Shaji RV, Srivastava A, Chandy M. Mathews V, et al. Among authors: abraham a. J Clin Oncol. 2010 Aug 20;28(24):3866-71. doi: 10.1200/JCO.2010.28.5031. Epub 2010 Jul 19. J Clin Oncol. 2010. PMID: 20644086 Clinical Trial.
The t(6;9)(p22;q34) in myeloid neoplasms: a retrospective study of 16 cases.
Gupta M, Ashok Kumar J, Sitaram U, Neeraj S, Nancy A, Balasubramanian P, Abraham A, Mathews V, Viswabandya A, George B, Chandy M, Srivastava A, Srivastava VM. Gupta M, et al. Among authors: abraham a. Cancer Genet Cytogenet. 2010 Dec;203(2):297-302. doi: 10.1016/j.cancergencyto.2010.08.012. Cancer Genet Cytogenet. 2010. PMID: 21156248
Cytogenetic analysis of acute myeloid leukemia with t(8;21) from a tertiary care center in India with correlation between clinicopathologic characteristics and molecular analysis.
Parihar M, Kumar JA, Sitaram U, Balasubramanian P, Abraham A, Viswabandya A, George B, Mathews V, Srivastava A, Srivastava VM. Parihar M, et al. Among authors: abraham a. Leuk Lymphoma. 2012 Jan;53(1):103-9. doi: 10.3109/10428194.2011.603447. Epub 2011 Sep 2. Leuk Lymphoma. 2012. PMID: 21745004
Mast cell sarcoma of the small intestine: a case report.
Bugalia A, Abraham A, Balasubramanian P, Srivastava A, Nair S. Bugalia A, et al. Among authors: abraham a. J Clin Pathol. 2011 Nov;64(11):1035-7. doi: 10.1136/jclinpath-2011-200154. Epub 2011 Jul 21. J Clin Pathol. 2011. PMID: 21778298 No abstract available.
Role of minimal residual disease monitoring in acute promyelocytic leukemia treated with arsenic trioxide in frontline therapy.
Chendamarai E, Balasubramanian P, George B, Viswabandya A, Abraham A, Ahmed R, Alex AA, Ganesan S, Lakshmi KM, Sitaram U, Nair SC, Chandy M, Janet NB, Srivastava VM, Srivastava A, Mathews V. Chendamarai E, et al. Among authors: abraham a. Blood. 2012 Apr 12;119(15):3413-9. doi: 10.1182/blood-2011-11-393264. Epub 2012 Feb 28. Blood. 2012. PMID: 22374701 Free article.
2,407 results